Bank of New York Mellon Corp Sells 28,569 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Bank of New York Mellon Corp lowered its position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 3.2% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 870,921 shares of the company's stock after selling 28,569 shares during the period. Bank of New York Mellon Corp owned 0.70% of Henry Schein worth $60,268,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Farther Finance Advisors LLC increased its holdings in Henry Schein by 58.9% during the third quarter. Farther Finance Advisors LLC now owns 933 shares of the company's stock worth $68,000 after buying an additional 346 shares during the last quarter. Radnor Capital Management LLC bought a new stake in shares of Henry Schein in the 3rd quarter worth approximately $1,100,000. Principal Financial Group Inc. increased its stake in shares of Henry Schein by 2.1% in the third quarter. Principal Financial Group Inc. now owns 145,835 shares of the company's stock worth $10,631,000 after buying an additional 3,037 shares during the period. Olstein Capital Management L.P. increased its position in Henry Schein by 8.1% during the 3rd quarter. Olstein Capital Management L.P. now owns 93,000 shares of the company's stock valued at $6,780,000 after purchasing an additional 7,000 shares during the period. Finally, Covestor Ltd increased its position in Henry Schein by 31.2% during the 3rd quarter. Covestor Ltd now owns 1,987 shares of the company's stock valued at $144,000 after purchasing an additional 473 shares during the period. Institutional investors and hedge funds own 96.62% of the company's stock.

Henry Schein Stock Up 1.6 %

Shares of NASDAQ:HSIC traded up $1.15 during midday trading on Wednesday, hitting $71.46. 2,532,278 shares of the stock were exchanged, compared to its average volume of 1,479,525. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. Henry Schein, Inc. has a 52-week low of $63.67 and a 52-week high of $82.49. The business's fifty day simple moving average is $74.42 and its two-hundred day simple moving average is $72.51. The company has a market capitalization of $8.87 billion, a PE ratio of 29.41, a P/E/G ratio of 2.13 and a beta of 0.91.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing analysts' consensus estimates of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm had revenue of $3.19 billion for the quarter, compared to analyst estimates of $3.25 billion. During the same period last year, the business earned $0.66 earnings per share. The firm's quarterly revenue was up 5.8% compared to the same quarter last year. As a group, research analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research firms have issued reports on HSIC. Barrington Research restated an "outperform" rating and set a $90.00 target price on shares of Henry Schein in a research note on Wednesday, February 26th. StockNews.com upgraded Henry Schein from a "sell" rating to a "hold" rating in a research report on Thursday, November 7th. Mizuho began coverage on Henry Schein in a research note on Wednesday, December 4th. They issued a "neutral" rating and a $75.00 target price on the stock. Wells Fargo & Company assumed coverage on Henry Schein in a report on Friday, February 14th. They set an "equal weight" rating and a $80.00 target price for the company. Finally, Bank of America raised Henry Schein from an "underperform" rating to a "buy" rating and boosted their price target for the company from $69.00 to $84.00 in a report on Monday, January 6th. Six equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $81.10.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.